Highest-materiality recent filing
biote Corp. 2026 annual meeting elects directors, ratifies Deloitte as auditor
Andrew R. Heyer elected Class I director with 22,759,692 for, 3,960,800 withheld; 2,861,704 broker non-votes.
Biote Q1 revenue $44.9M (-8.3% YoY); net income $2.7M vs $15.8M, hit by hormone pellet recall
Revenue $44.9M, down 8.3% YoY; net income $2.7M ($0.06 EPS) vs $15.8M ($0.37) in Q1 2025.
biote Corp. posts April 2026 investor presentation on its website
Presentation dated April 2026 available at ir.biote.com/news-events/presentations.
Biote Q4 revenue $46.4M; net income $2.6M; anticipates procedure growth H2 2026
Q4 2025 revenue $46.4M, gross margin 68.0%; net income $2.6M ($0.06 diluted EPS), down from $3.5M ($0.10) in Q4 2024.
Biote subsidiary recalls hormone pellets due to metal particulate; expects $1.3M Q4 charge
Asteria Health voluntarily recalled specific lots of hormone pellets shipped May 20, 2025–Jan 19, 2026 due to potential metal particulate.
Biote Q3 2025: Revenue $48.0M, net income $9.2M ($0.22 EPS), down YoY
Revenue $48.0M, gross profit margin 71.8%.
Biote Q2 rev $48.9M, net income $3.9M vs year-ago loss; Adj. EBITDA up 19%
Revenue $48.9M, gross margin 71.6%; net income $3.9M ($0.10 diluted EPS) vs net loss $10.4M ($0.21 loss) in Q2 2024.
biote Corp appoints Rich Barrera to Board, filling Heyer vacancy
Richard R. Barrera appointed as Class II director effective June 5, 2025; term expires at 2027 annual meeting.
Director Steven J. Heyer resigns from biote Corp board effective June 2, 2025
Steven J. Heyer resigned from the board of directors effective June 2, 2025.
On June 5, 2025, the Board of Directors (the “Board”) of biote Corp. (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee, appointed Richard R. Barrera to serve as a member of the Board to fill the vacancy created by the prior resignation of Steven J. Heyer
vacancy created by the prior resignation of Steven J. Heyer
On June 2, 2025, Steven J. Heyer notified the Board of Directors (the “Board”) of biote Corp. (the “Company”) of his resignation as a member of the Board, effective immediately.
Max materiality 0.85 · Median 0.55 · Most common event earnings